Sanity Group announces successful closing of acquisition by Organigram
The transaction values Sanity Group at up to €250 million. Both companies aim to accelerate growth in Europe. Sanity continues operations with its team and brands.
See the latest news and media coverage for Sanity Group. We track all announcements, press releases, and industry mentions in real time, all in one place.
European medical cannabis company
sanitygroup.comLast updated
In short: Sanity Group was acquired by Organigram Global for up to $250 million, marking a major consolidation in the European medical cannabis market.
The transaction values Sanity Group at up to €250 million. Both companies aim to accelerate growth in Europe. Sanity continues operations with its team and brands.
The merger integrates Sanity's European platform with Organigram's production and innovation expertise, creating a vertically integrated value chain from cultivation to patient access.
EKOCAN interim report shows stable consumption, declining adolescent use, and shift to legal sources. Company warns against hasty amendments and pushes for pilot retail projects.
Reforms must consider supply security and economic efficiency. Savings potentials must not ignore consequential costs.
Organigram Global Inc. (NASDAQ:OGI) is one of the 10 best tobacco and cigarette stocks to invest in. On April 15, Organigram Global Inc. (NASDAQ:OGI) finalized...
BT DE Investments, a British American Tobacco affiliate, now owns 29.9% of Organigram’s Common Shares plus all Preferred Shares following the Sanity Group deal and...
Detailed price information for Organigram Global Inc (OGI-Q) from The Globe and Mail including charting and trades.
We recently compiled a list of the 10 Best Cheap Stocks Under $10 to Buy in April. Organigram Global Inc. is among the best cheap...
Track Sanity Group and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Sanity Group and other trending companies.